ELAINE MARISKI: Open Payments
NPI 1174093504 · ENCINITAS, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$852 in 34 payments from 12 companies in 2025. Trend: 2023 $1,010 · 2024 $772 · 2025 $852
Food & beverage: $852
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 8 | $176 |
| Edwards Lifesciences Corporation | 1 | $173 |
| Amgen Inc. | 6 | $109 |
| PFIZER INC. | 3 | $78 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $67 |
| Regeneron Healthcare Solutions, Inc. | 3 | $61 |
| Boston Scientific Corporation | 3 | $54 |
| Alnylam Pharmaceuticals Inc. | 2 | $44 |
| Novo Nordisk Inc | 1 | $29 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $27 |
Products named: LEQVIO, SAPIEN 3 Ultra RESILIA, ELIQUIS, REPATHA, JARDIANCE, EVKEEZA, AMVUTTRA, CDS - MCT/CEM Monitoring.
Industry payments across CA — which companies pay providers there.
